The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELTA.L Regulatory News (ELTA)

  • There is currently no data for ELTA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Strategic Review - Phase II

23 Oct 2017 07:00

RNS Number : 2653U
Electra Private Equity PLC
23 October 2017
 

Electra Private Equity PLC

 

Result of Strategic Review - Phase II

 

London 23 October 2017

 

 

The Board of Electra Private Equity PLC (the "Company") today announces the outcome of the second phase ("Phase II") of its strategic review as first announced on 25 January 2016 ("the Review"). The commencement of Phase II was announced on 1 June 2017, following assumption of responsibilities from the former manager.

 

The principal objective of the Review is to maximise long-term shareholder value by assessing the Company's investment strategy and policy and its structure.

 

The key outcomes of activity undertaken since Phase I of the Review was announced in October 2016 have been:

§ The Company has completed the handover of the investment portfolio and operational responsibilities from its former external manager.

§ The resources required to pursue the strategy announced today are now in place.

§ Recurring annual management expenses have been reduced from approximately £33 million to approximately £5 million.

§ The Company has completed the disposal of all of its Funds, Secondaries, Debt, and Listed assets. Certain of these disposals are signed but not yet closed. A portfolio update based on published 31 March 2017 valuations is shown below.

§ A robust and sustainable corporate governance structure has been implemented with the Board responsible for continued delivery for shareholders.

§ Since the resumption of distributions to shareholders in 2015, including today's announced dividend the Company has distributed £1.9 billion (approximately £49.50 per share) to shareholders.

Strategic Review: Phase II

The key outcomes of Phase II of the Strategic Review are:

· The Board intends to continue its strategy of focusing on optimising return on shareholder capital. The Board considers that current market conditions do not support new investment. However, should conditions change the Board will consider further investment.

· In line with this capital allocation strategy, the Board is today declaring a further special dividend of £350 million, or 914p per share. This is to be paid on 1 December 2017 to shareholders on the register of members at the close of business on 3 November 2017.*

· Subject to shareholder and regulatory approval the Company will update its investment policy to reflect a focus on shareholder returns and will explore options for reclassification of its current listing.

· Taxation benefits related to the realisation of assets currently provided through the Company's Investment Trust Company tax status are expected to be obtained through the Substantial Shareholding Exemption (SSE) should its listing classification change.

· Actions will be taken to further simplify the Group's corporate and underlying partnership structures realising cost and efficiency benefits.

· The Company intends to change its name to remove the words "Private Equity" to better reflect its revised strategic focus.

· The Board intends to convene a general meeting in due course to allow shareholders to vote on these proposals.

Current Pro Forma Composition of Net Asset Value

(Based on Unaudited 31 March 2017 valuations)

Pro Forma as at 23 October 2017(1)

(£ millions)

Investment Value

Attributable Carried Interest

Net Asset Value

NAV per Share (pence)

TGI Fridays(2)

 156.6

 (17.3)

 139.3

 364p

Hotter Shoes

 43.0

 (6.1)

 36.9

 96p

Subtotal Buyouts

 199.6

 (23.5)

 176.1

 460p

Photobox

 103.8

 (4.6)

 99.2

 259p

Knight Square

 26.5

 (3.8)

 22.7

 59p

Sentinel

 3.0

 (0.4)

 2.6

 7p

Other Co-investments

 2.8

 (0.5)

 2.3

 6p

Subtotal Co-investments

 136.1

 (9.3)

 126.8

 331p

Investment Portfolio

 335.6

 (32.7)

 302.9

 791p

Cash and Cash Equivalents(3)

 435.1

 1,137p

Assets Sold but not Yet Closed

 42.4

111p

Other Net Assets/(Liabilities)

 (4.0)

 (10p)

Net Asset Value

 776.5

 2,028p

 

Giving effect to the 914p dividend declared by the Company on 23 October 2017, pro forma net asset value would be £426.6 million (1,114p per share), comprised of net investments of £302.9 million, net cash balances of £81.2 million, and assets sold but not yet closed of £42.4 million.

(1) Carrying values as at 31 March 2017 pending completion of year-end audit; reflects purchase of the former manager's 1% interest following termination

(2) Gives effect to additional £35 million invested to support refinancing

(3) Prior to payment of dividend announced 23 October 2017

 

Updated valuations as at 30th September 2017 will be published with the Group's results to 30th September 2017 in December.

Neil Johnson, Chairman of Electra Private Equity PLC, said today:

"I am pleased to present the findings of Phase II of the strategic review to shareholders. Having had the opportunity to review the portfolio fully for the first time, the Board remains firm in its conviction that the changes identified and implemented through the review process have been essential to driving shareholder returns both at the present time and in the future. Our analysis of the portfolio has also highlighted opportunities to create genuine value as opposed to transient shifts in valuation or financial engineering.

The Company has the required operational resources in place while benefitting significantly from the sizeable reduction in costs. Consistent with our stated aim to return excess capital to shareholders, I am delighted to announce a further special dividend taking total distributions to £1.9 billion since the resumption of distributions to shareholders in 2015. We will continue to manage the Company's capital needs closely with a view to optimising returns for shareholders.

We are also taking the first steps towards migration of the Company from a listed investment trust to a structure that we believe represents a more flexible platform for the future. At the same time we will change our name to remove the words "Private Equity" from our name to more accurately reflect the nature of the business in this exciting phase of its development and I look forward to discussing these and other matters with our shareholders in due course."

 

* The special dividend will not fall within the Dividend Reinvestment Plan.

- Ends -

 

 

Electra Private Equity PLC will host a meeting with investors and analysts at 10:00am BST today at Brunswick Group, 16 Lincoln's Inn Fields, London, WC2A 3ED. Participants wishing to join by telephone can use the dial-in details as follows:

 

Participant Dial-in: +44 (0) 14 5255 5566

Conference ID: 3295239

 

A Company presentation for investors is available at www.electraequity.com.

 

For further information:

Gavin Manson +44 (0) 20 3874 8300

Chief Financial Officer

 

Brunswick Group LLP +44 (0) 20 7404 5959

Gill Ackers/Rowan Brown Electra@brunswickgroup.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMMZGNZFGNZM
Date   Source Headline
15th Sep 201712:12 pmRNSDirector Declaration
31st Jul 201712:05 pmRNSDirector Declaration
24th Jul 20174:48 pmRNSHolding(s) in Company
18th Jul 20171:54 pmRNSHolding(s) in Company
17th Jul 20177:00 amRNSDirector/PDMR Shareholding
12th Jul 20179:14 amRNSDirector Declaration
27th Jun 20179:39 amRNSHalf-year Report
19th Jun 201710:15 amRNSDirector/PDMR Shareholding
14th Jun 20173:22 pmRNSDirector/PDMR Shareholding
14th Jun 20173:22 pmRNSDirector/PDMR Shareholding
13th Jun 20175:25 pmRNSDirector/PDMR Shareholding
8th Jun 20173:46 pmRNSDirector/PDMR Shareholding
1st Jun 20177:00 amRNSCompany Update
25th May 20177:00 amRNSHalf-year Report
24th May 201711:04 amRNSEpiris announces the sale of PINE Unit Trust
15th May 20177:00 amRNSEpiris announces the sale of TechInsights
24th Apr 201712:28 pmRNSChange of Registered Office
21st Apr 20177:00 amRNSEpiris receives £67 million from the sale of RISI
19th Apr 20177:00 amRNSEpiris Sells CALA & Retirement Bridge Investments
7th Apr 20177:42 amRNSEpiris sells remaining stake in Hollywood Bowl
7th Apr 20177:00 amRNSEpiris completes the sale of Treetops Nurseries
31st Mar 20177:00 amRNSEpiris completes the sale of Audiotonix
30th Mar 20179:40 amRNSHolding(s) in Company
30th Mar 20177:00 amRNSEpiris agrees the sale of Treetops Nurseries
24th Mar 20177:00 amRNSSpecial Dividend
23rd Mar 20174:39 pmRNSDirectorate Change
23rd Mar 20174:34 pmRNSResolutions passed at AGM - 23 March 2017
23rd Mar 20171:12 pmRNSResult of AGM
23rd Mar 20177:00 amRNSEpiris announces the realisation of Allflex
17th Mar 20174:35 pmRNSPrice Monitoring Extension
6th Mar 20177:00 amRNSEpiris completes £1.35b sale of Parkdean Resorts
6th Mar 20177:00 amRNSEpiris completes sale of interest in Innovia Group
3rd Mar 20177:06 amRNSEpiris announces the sale of RISI for $125 million
16th Feb 20177:04 amRNSEpiris announces the sale of OAG
3rd Feb 20177:00 amRNSEpiris announces the sale of Audiotonix
30th Jan 20174:25 pmRNSNotice of AGM
30th Jan 20174:25 pmRNSAnnual Financial Report
30th Jan 201710:00 amRNSEpiris sells Davies Group for £90 million
3rd Jan 201710:56 amRNSTotal Voting Rights
28th Dec 20162:27 pmRNSHolding(s) in Company
23rd Dec 20163:29 pmRNSNotification of cancelled shares, Voting Rights
23rd Dec 20163:16 pmRNSHolding(s) in Company
22nd Dec 20165:27 pmRNSDirector/PDMR Shareholding
22nd Dec 20167:00 amRNSResults of Tender Offer
20th Dec 20167:00 amRNSSale of Electra's interest in Innovia announced
19th Dec 20167:00 amRNSEpiris agrees £1.35b sale of Parkdean Resorts
14th Dec 20164:58 pmRNSHolding(s) in Company
9th Dec 20167:00 amRNSPreliminary Announcement for the Full Year
2nd Dec 20162:55 pmRNSResult of Meeting
18th Nov 20167:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.